Large-scale DNA sequencing and gene identification are the foundation of Millennium Pharmaceuticals Inc.'s expertise, so it is not intuitively obvious why the company would do deals with other companies in these areas, as it did last week with Incyte Pharmaceuticals Inc. and Lexicon Genetics Inc.

But as MLNM needs ever more targets for its pharmaceutical partners and its own internal drug